EN
IT
Invasive Prenatal Diagnosis
Screening for chromosome abnormalities and genetic disorders in fetus during pregnancy
Technological advancements have determined the introduction of sophisticated genetic tests into medical practice, for the evaluation of the pregnancy and fetal health.
GENOMICA can boast one of the most extensive experience in the field of prenatal diagnostics, which allow the company to make the most advanced technologies available in the field to pregnant women and their gynecologists, for the diagnosis of chromosomal abnormalities and genetic disorders in the fetus.
GENOMICA is able to perform all genetic testing that can be offered at prenatal stage. This allows the couple to obtain very useful information on any fetal anomaly from the first weeks of pregnancy, and consequently promptly prepare a therapeutic intervention aimed at safeguarding the health of the unborn child and to ensure the best life condition.
An advanced molecular test that, using the latest generation of fully automated technologies, determines the fetal karyotype with high accuracy and resolution.
DNA obtained from CVS or amniotic fluid following an invasive procedure, to screen for monogenic disorders in the fetus.
An advanced prenatal genetic test performing Whole Exome Sequencing (WES), i.e. the sequencing of the entire exome of the fetal DNA. It represents one of the most complete prenatal test for the identification of pathogenic DNA mutations, causing numerous fetal genetic diseases.
